LIFEVANTAGE CORP Long-Term Debt
LIFEVANTAGE CORP (LFVN) had Long-Term Debt of $0 as of 2019-06-30, per its 10-K filed 2019-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2019-08-14
- 2019-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2019-03-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2018-12-31: Long-term Debt, Excluding Current Maturities $2.43M.
- 2018-09-30: Long-term Debt, Excluding Current Maturities $2.92M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2019-06-30 | $0.00 10-K · filed 2019-08-14 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $2.43M 10-Q · filed 2019-02-04 | |
| 2018-09-30 | $2.92M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $3.41M 10-K · filed 2019-08-14 | |
| 2018-03-31 | $3.96M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $4.46M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $4.95M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $5.44M 10-K · filed 2018-08-15 | |
| 2017-03-31 | $5.93M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $6.42M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $6.92M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $7.41M 10-K · filed 2017-09-07 | |
| 2016-03-31 | $7.90M 10-Q/A · filed 2016-07-19 | |
| 2015-12-31 | $1.04M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $5.02M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $8.53M 10-K · filed 2016-12-12 | $9.63M 10-K · filed 2015-09-01 |
| 2015-03-31 | $17.20M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $22.82M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $23.95M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $25.07M 10-K · filed 2015-09-01 | |
| 2013-06-30 | $0.00 10-K · filed 2014-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |